Last reviewed · How we verify
Inactivated trivalent influenza vaccine
Inactivated trivalent influenza vaccine is a Biologic drug developed by Advagene Biopharma Co. Ltd.. It is currently FDA-approved. Also known as: VAXIGRIP vaccine, Flu Vaccines, Influenza Virus Vaccines, Influenza Vaccine, Trivalent.
At a glance
| Generic name | Inactivated trivalent influenza vaccine |
|---|---|
| Also known as | VAXIGRIP vaccine, Flu Vaccines, Influenza Virus Vaccines, Influenza Vaccine, Trivalent, Vaccine, Trivalent Influenza |
| Sponsor | Advagene Biopharma Co. Ltd. |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Longitudinal Tracking of Bone Marrow Plasma Cell Responses to Licensed Human Vaccines (PHASE4)
- Influenza Vaccination Strategy for Patients With Hematologic Malignancy (PHASE3)
- Immunogenicity and Safety Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) in Adults Aged 50 Years and Older (PHASE3)
- Study to Evaluate Immunogenicity and Safety of a High-Dose Influenza Vaccine in Adults 50 Through 64 Years of Age (PHASE3)
- Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (PHASE3)
- High vs. Standard Dose Influenza Vaccines in Lung Transplant (Repeater) (PHASE2)
- A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision (EARLY_PHASE1)
- Immunogenicity and Safety of Butantan Quadrivalent Influenza Vaccine (Split Virion, Inactivated) in Infants and Children . (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Inactivated trivalent influenza vaccine CI brief — competitive landscape report
- Inactivated trivalent influenza vaccine updates RSS · CI watch RSS
- Advagene Biopharma Co. Ltd. portfolio CI
Frequently asked questions about Inactivated trivalent influenza vaccine
What is Inactivated trivalent influenza vaccine?
Inactivated trivalent influenza vaccine is a Biologic drug developed by Advagene Biopharma Co. Ltd..
Who makes Inactivated trivalent influenza vaccine?
Inactivated trivalent influenza vaccine is developed and marketed by Advagene Biopharma Co. Ltd. (see full Advagene Biopharma Co. Ltd. pipeline at /company/advagene-biopharma-co-ltd).
Is Inactivated trivalent influenza vaccine also known as anything else?
Inactivated trivalent influenza vaccine is also known as VAXIGRIP vaccine, Flu Vaccines, Influenza Virus Vaccines, Influenza Vaccine, Trivalent, Vaccine, Trivalent Influenza.
What development phase is Inactivated trivalent influenza vaccine in?
Inactivated trivalent influenza vaccine is FDA-approved (marketed).
Related
- Manufacturer: Advagene Biopharma Co. Ltd. — full pipeline
- Also known as: VAXIGRIP vaccine, Flu Vaccines, Influenza Virus Vaccines, Influenza Vaccine, Trivalent, Vaccine, Trivalent Influenza
- Compare: Inactivated trivalent influenza vaccine vs similar drugs
- Pricing: Inactivated trivalent influenza vaccine cost, discount & access